Products
Platform
Research
Market
Learn
Partner
Support
IPO

Z

Zenotech Laboratories Share Price

45.62
-0.62 (-1.34%)
ZENOTECH • 26 Dec, 2025 | 03:29 PM

1Y Annualised Return

-34.60%

3Y Annualised Return

-9.84%

5Y Annualised Return

7.72%

10Y Annualised Return

0.58%

The current prices are delayed, login or Open Demat Account for live prices.

Zenotech Laboratories Stock Performance

1W Return3.14
1Y Return-35.47
Today's Low45.32
Prev. Close46.24
Mkt Cap (Cr.)278.42
1M Return-6.32
3Y Return-27.59
52-Week High73.3
Open45.32
PE Ratio97.06
6M Return-25.46
Today's High46.75
52-Week Low43.85
Face Value10

Zenotech Laboratories Company background

Founded in: 1989
Zenotech Laboratories Limited was initially established as Sunline Technologies Limited in June, 1989 and changed to the present name w.e.f. August 9, 2004. Company is a loan licensing company catering exclusively to Sun Pharmaceutical Industries Limited, Promoter holding company and they are specialized contract manufacturing services /processing in parenteral depot formulations, ophthalmic, oncology oral injectables and general injectables. Companys injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology.During financial year 200405, the Honble High Court of Andhra Pradesh sanctioned the Scheme of Amalgamation with M/s. Zenotech Technologies Limited with effect from November 1st , 2003. The Company had issued 91,82,500 equity shares to erstwhile shareholders of M/s. Zenotech Laboratories Pvt. Ltd. M/s, Credence Pharmaceuticals Limited and M/s, Hemarus Healthcare Private Limited were merged with the Company, on May 2, 2006 through Scheme of Amalgamation, effective from October 1, 2005. 15 generic chemical oncology products were launched by the Company in India. Besides, the Company launched its anesthesia range of products during 2006.In 200506, M/s, Credence Pharmaceuticals Limited and M/s, Hemarus Healthcare Private Limited got merged with the Company and the Scheme of Amalgamation became effective from October 1, 2005. Consequent to the consummation of the merger of Ranbaxy Laboratories Limited into SPIL on March 24, 2015, SPIL indirectly acquired 46.84 percent of the voting rights held by Ranbaxy in, and control over the Company and became Promoter of the Company along with Daiichi Sankyo Company Limited and resultant, the Open Offer concluded in August 2015.The Company started production from its newly commissioned Depot Injectable facility in FY 201920. It renovated Biotech API manufacturing facility and the same was leased to Sun Pharmaceutical Industries Limited, for their RD activities effective from July, 2021.

Zenotech Laboratories Share Price Today


As of 27 Dec 2025, Zenotech Laboratories share price is ₹45.6. The stock opened at ₹45.3 and had closed at ₹46.2 the previous day. During today’s trading session, Zenotech Laboratories share price moved between ₹45.32 and ₹46.75, with an average price for the day of ₹46.03. Over the last 52 weeks, the stock has recorded a low of ₹43.85 and a high of ₹73.30. In terms of performance, Zenotech Laboratories share price has declined by 25.5% over the past six months and has declined by 34.6% over the last year.
Read More
Zenotech Laboratories SIP Return Calculator
5,000
Over the past
Total Investment of ₹0
Monthly SIP of 5,000 would have become 0 in 5 years with a gain of 0 (+0.00%)
View details of Market Depth

Zenotech Laboratories Fundamental

Market Cap (in crs)

278.42

Face Value

10

Turnover (in lacs)

4.37

Key Metrics

Qtr Change %
Near 52W Low of ₹43.85
-12.2
Dividend yield 1yr %
0

Zenotech Laboratories Shareholding Pattern

Promoter
68.8%
Domestic Institutions
1%
Public
30.2%

Zenotech Laboratories Technical Analysis

Moving Averages Analysis
45.62
Current Price
Bullish Moving Averages
1
Bearish Moving Averages
15
Day EMA5
45.80
Day EMA10
45.80
Day EMA12
46.00
Day EMA20
46.50
Day EMA26
46.90
Day EMA50
48.60
Day EMA100
51.30
Day EMA200
55.40
Delivery & Volume
Loading chart...

Day

68.30%

Week

82.30%

Month

86.00%

Delivery & Volume

45.90
Pivot
Resistance
First Resistance
46.47
Second Resistance
47.33
Third Resistance
47.90
Support
First Support
45.04
Second support
44.47
Third Support
43.61
Relative Strength Index
41.89
Money Flow Index
23.71
MACD
-0.98
MACD Signal
-1.12
Average True Range
1.62
Average Directional Index
23.68
Rate of Change (21)
-6.32
Rate of Change (125)
-25.46
Compare

Zenotech Laboratories Latest News

26 DEC 2025 | Friday
01 NOV 2025 | Saturday
31 OCT 2025 | Friday

Please be aware that Zenotech Laboratories stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account